Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management

Research output: Contribution to journalComment/debatepeer-review

26 Scopus citations
Original languageEnglish (US)
Pages (from-to)1152-1160
Number of pages9
JournalCancer
Volume126
Issue number6
DOIs
StatePublished - Mar 15 2020

Keywords

  • acute lymphoblastic leukemia
  • blinatumomab
  • hyperCVAD
  • hyperfractionated cyclophosphamide
  • inotuzumab
  • safety

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this